IL22 and carcinoma: Our present study shows that IL-22 affects several important functions of OSCC cells via the STAT3-dependent and/or -independent pathways, suggesting that IL-22 may play a role in carcinoma cell differentiation and the upregulation of SERPINB3/B4, well-known biomarkers for SCC.